July 2026
Added to Dediabetes Jul 12, 2026RCTs
This study evaluated the effects of Curcuma longa extract on neuropathy symptoms and vascular biomarkers in adults with type 2 diabetes, finding significant improvements in several measures.
Interventions
Curcuma longa extract (CLE)
Outcomes
Hyaluronic acid (HA)Matrix metalloproteinase-2 (MMP-2)Matrix metalloproteinase-9 (MMP-9)+8 more
Added to Dediabetes Jul 12, 2026RCTs
Curcumin supplementation was studied for its effects on inflammatory and glycemic profiles in adults with type 2 diabetes, showing significant improvements in several key metrics.
Interventions
Curcumin supplementation
Outcomes
C-reactive proteinFasting Plasma Glucose (FPG)Glutathione peroxidase (GPx)+6 more
Added to Dediabetes Jul 12, 2026RCTs
The study evaluated the effects of a curcumin-piperine combination on mental health and physical factors in diabetic retinopathy patients, showing significant improvements in various outcomes.
Interventions
Curcumin plus piperine
Outcomes
Anxiety scoreBMIDepression score+3 more
Added to Dediabetes Jul 12, 2026RCTs
The study evaluated the effects of curcumin-piperine supplementation on oxidative stress and kidney function in diabetic retinopathy patients, finding significant improvements in antioxidant capacity and creatinine levels.
Interventions
Curcumin plus piperine
Outcomes
Blood urea nitrogen (BUN)C-reactive proteinFasting Plasma Glucose (FPG)+7 more
Added to Dediabetes Jul 12, 2026RCTs
Dairy-enriched diet vs non-dairy isoenergetic diet in adults with type 2 diabetes.
Interventions
YesMilk diet
Outcomes
BMAL1 gene expression increaseCRY1 gene expression increaseFasting Plasma Glucose (FPG)+5 more
Added to Dediabetes Jul 12, 2026Cohort
This study investigated the effects of dapagliflozin on the renin-angiotensin-aldosterone system in patients with type 2 diabetes, finding significant changes in several metabolic parameters.
Interventions
Dapagliflozin
Outcomes
BMIDiastolic blood pressureFasting blood sugar (FBS)+8 more
Added to Dediabetes Jul 12, 2026RCTs
This study investigated the neuroprotective effects of dapagliflozin and liraglutide in patients with type 2 diabetes, highlighting distinct outcomes on brain function.
Interventions
DapagliflozinLiraglutide
Outcomes
Attention improvementMemory performanceOlfactory task functional connectivity+3 more
Added to Dediabetes Jul 12, 2026RCTs
This study evaluated the addition of dapagliflozin to insulin pump therapy in patients with Type 2 diabetes, finding significant improvements in glycemic targets and insulin dosage.
Interventions
Insulin therapyMetformin
Outcomes
Assessment of pancreatic function through insulin and C-peptide levelsTime to glycemic targetTotal daily insulin dose
Added to Dediabetes Jul 12, 2026RCTs
This study compared the effects of dapagliflozin and vitamin E in patients with metabolic dysfunction-associated steatotic liver disease and type 2 diabetes, finding significant improvements in several metabolic parameters with dapagliflozin.
Interventions
Dapagliflozin
Outcomes
ASTAlanine Aminotransferase (ALT)BMI+8 more
Added to Dediabetes Jul 12, 2026RCTs
This study evaluated the combination therapy of Dapagliflozin and Linagliptin in managing Type 2 Diabetes and hypertension, showing significant improvements in various health metrics.
Interventions
Dapagliflozin
Outcomes
Alanine Aminotransferase (ALT)Estimated glomerular filtration rateFasting Plasma Glucose (FPG)+5 more